ABBV - AbbVie

-

$undefined

N/A

(N/A)

AbbVie NEW YORK STOCK EXCHANGE INC.:ABBV AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

Location: 1 N Waukegan Rd, Illinois, 60064-1802, US | Website: www.abbvie.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

401.1B

Cash

13.16B

Avg Qtr Burn

N/A

Short % of Float

0.84%

Insider Ownership

0.09%

Institutional Own.

73.39%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Tavapadon (adjunct with L-Dopa) Details
Parkinson's disease, Brain disease

Phase 3

Data readout

Tavapadon Details
Parkinson's disease, Brain disease

Phase 3

Data readout

Darigabat Details
Social Anxiety Disorder, Panic Disorder

Phase 2

Data readout

Phase 2

Data readout

Emraclidine (CVL-231) Details
Brain disease, Schizophrenia

Phase 2

Data readout

Phase 2

Data readout

Emraclidine (CVL-231) Details
Brain disease, Neurodegenerative disease, Alzheimer's disease

Phase 1

Data readout

CVL-354 Details
Major depressive disorder

Phase 1

Data readout